Age-related Macular Degeneration

X-Linked Retinitis Pigmentosa: Integrating Genetic Testing and Counseling to Improve Assessment and the Promise of Gene Therapy

X-Linked Retinitis Pigmentosa: Integrating Genetic Testing and Counseling to Improve Assessment and the Promise of Gene Therapy

X-linked retinitis pigmentosa (XLRP) is a rare, inherited retinal disease …

Expiration Date: 11/16/2022

Max Credits: 1.25

View Activity

Innovative Treatment Protocols That Can Redefine the Management of nAMD and DR

Innovative Treatment Protocols That Can Redefine the Management of nAMD and DR

Treatment protocols utilizing intravitreal anti-vascular endothelial growt…

Expiration Date: 10/18/2022

Max Credits: 0.75

View Activity

Futuristic Approaches That Reduce Treatment Burden in Age-related Macular Degeneration and Diabetic Macular Edema

Futuristic Approaches That Reduce Treatment Burden in Age-related Macular Degeneration and Diabetic Macular Edema

Anti-vascular endothelial growth factor (anti-VEGF) therapy has been the m…

Expiration Date: 10/6/2022

Max Credits: 0.75

View Activity

A Closer Look at Emerging Delivery Systems That Can Improve the Treatment of Age-related Macular Degeneration and Diabetic Macular Edema

A Closer Look at Emerging Delivery Systems That Can Improve the Treatment of Age-related Macular Degeneration and Diabetic Macular Edema

Visual acuity outcomes observed with intravitreal anti-vascular endothelia…

Expiration Date: 8/12/2022

Max Credits: 1.25

View Activity

Applying Emerging Evidence to Practice in Managing AMD and DME

Applying Emerging Evidence to Practice in Managing AMD and DME

The inclusion of anti-VEGF therapies revolutionized the treatment of neova…

Expiration Date: 8/12/2022

Max Credits: 1.25

View Activity

Innovative Approaches to Reducing Treatment Burden in Age-related Macular Degeneration and Diabetic Macular Edema

Innovative Approaches to Reducing Treatment Burden in Age-related Macular Degeneration and Diabetic Macular Edema

Less than optimal visual acuity gains in patients with neovascular age-rel…

Expiration Date: 8/4/2022

Max Credits: 0.75

View Activity

Lengthening the Treatment Interval in Age-related Macular Degeneration: Current Status and Insights

Lengthening the Treatment Interval in Age-related Macular Degeneration: Current Status and Insights

Intravitreal antivascular endothelial growth factor therapy has revolution…

Expiration Date: 6/29/2022

Max Credits: 0

View Activity

Diabetic Macular Edema Management in 2021: What’s New?

Diabetic Macular Edema Management in 2021: What’s New?

Although anti-VEGF therapy has revolutionized the management of diabetic m…

Expiration Date: 6/17/2022

Max Credits: 0

View Activity

Neovascular AMD: Impact of Dosing Regimens and Residual Retinal Fluid on Long-Term Outcomes

Neovascular AMD: Impact of Dosing Regimens and Residual Retinal Fluid on Long-Term Outcomes

Intravitreal therapy has rapidly evolved to become a mainstay of treatment…

Expiration Date: 6/15/2022

Max Credits: 0

View Activity

Curbside Consults: Applying Real World Evidence to Practice When Selecting Treatment for nAMD

Curbside Consults: Applying Real World Evidence to Practice When Selecting Treatment for nAMD

Intravitreal therapy has rapidly evolved to become a mainstay of treatment…

Expiration Date: 5/30/2022

Max Credits: 0

View Activity